This compound is a quinazoline derivative used as a pharmaceutical intermediate in drug synthesis. It features a halogenated aromatic ring system with ether substituents, commonly employed in the manufacturing of active pharmaceutical ingredients.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 183322-21-6
3-Bromofuran
pharmaceutical intermediate for drug synthesis
2,4,6-Trichloropyrimidin-5-amine
pharmaceutical intermediate for drug synthesis
(Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic acid
pharmaceutical intermediate for drug synthesis
N-[5-(4-Bromophenyl)-6-chloro-4-pyrimidinyl]-N'-propylsulfamide
pharmaceutical intermediate for drug synthesis
Bdh succinate
Pharmaceutical intermediate for HIV protease inhibitors
4,6-diamino-2-chloropyrimidine-5-carbonitrile
pharmaceutical intermediate
6-amino-5-methylnicotinonitrile
Pharmaceutical intermediate
5-Bromo-2-iodopyrimidine
Pharmaceutical intermediate
4-chloro-6,7-bis(2-chloroethoxy)quinazoline
WXAZLCUYDRYLFC-UHFFFAOYSA-N
C1=C2C(=CC(=C1OCCCl)OCCCl)N=CN=C2Cl